All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YJ1221 | Anti-SLC7A8 (3F10) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 3F10 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ1516 | Anti-SLC7A8 (3F10) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 3F10 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-0120ZP2339 | Anti-SLC7A8 (7D6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 7D6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP2340 | Anti-SLC7A8 (7D6) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 7D6 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP2341 | Anti-SLC7A8 (4H10) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 4H10 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP2342 | Anti-SLC7A8 (4H10) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 4H10 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP2343 | Anti-SLC7A8 (CBYJL-106) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBYJL-106 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP2344 | Anti-SLC7A8 (CBYJL-106) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | CBYJL-106 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP2346 | Anti-SLC7A8 (3F10) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 3F10 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION